• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天花疫苗接种反应、预防及并发症治疗

Smallpox vaccination reactions, prophylaxis, and therapy of complications.

作者信息

Goldstein J A, Neff J M, Lane J M, Koplan J P

出版信息

Pediatrics. 1975 Mar;55(3):342-7.

PMID:238178
Abstract

Smallpox vaccination in the United States is a routine public health measure which has been under intensive review during the last decade. The most frequently occurring adverse reactions to vaccination are benign and require little or no systemic therapy. These reactions include accidental infection, erythematous and urticarial rash, and generalized vaccinia. Chickenpox occurring concurrently with vaccination presents no problem unless vaccinia has widely superinfected the chickenpox lesions. There is no risk to the pregnant woman who is vaccinated, but there is a slight risk that the fetus will develop fetal vaccinia. The vaccinia does not cause congenital malformations. Vaccinia hyperimmune globulin (VIG) in prophylactic dosage may be given to a pregnant woman who is traveling to a smallpox infected or endemic area in order to prevent fetal vaccinia. Vaccinia necrosum and eczema vaccinatum require vigorous systemic therapy with VIG, and often thiosemicarbazone. Post-vaccinial encephalitis, while frequently serious, has not been shown to be ameliorated by VIG therapy, although there are data which suggest VIG has some value in prophylaxis for encephalitis. Prophylaxis, prompt recognition, and proper therapy may reduce the fatality rates of these complications. Revaccination of patients who have suffered a complication is a frequent clinical problem. Revaccination of an individual who has had post-vaccinial encephalitis or vaccinia necrosum is contraindicated unless the risk of contracting smallpox outweighs the risk of the above two diseases. Revaccination of children who have had eczema vaccinatum is not contraindicated. Revaccination of children with a history of accidental infection or erythematous or urticarial rash presents no known or theoretically increased risk.

摘要

在美国,天花疫苗接种是一项常规公共卫生措施,在过去十年中受到了深入审查。接种疫苗最常见的不良反应是良性的,几乎不需要或根本不需要全身治疗。这些反应包括意外感染、红斑和荨麻疹皮疹以及全身性牛痘。接种疫苗时同时出现水痘一般没有问题,除非牛痘广泛感染了水痘病灶。接种疫苗的孕妇没有风险,但胎儿有轻微风险会患上胎儿牛痘。牛痘不会导致先天性畸形。对于前往天花感染地区或流行地区的孕妇,可以给予预防剂量的牛痘超免疫球蛋白(VIG),以预防胎儿牛痘。坏死性牛痘和牛痘性湿疹需要用VIG进行积极的全身治疗,通常还需要使用氨硫脲。接种后脑炎虽然通常很严重,但尚未证明VIG治疗能改善病情,不过有数据表明VIG在预防脑炎方面有一定价值。预防、及时识别和适当治疗可以降低这些并发症的死亡率。对出现并发症的患者进行再次接种是一个常见的临床问题。曾患接种后脑炎或坏死性牛痘的个体禁忌再次接种,除非感染天花的风险超过上述两种疾病的风险。曾患牛痘性湿疹的儿童再次接种并无禁忌。有意外感染或红斑或荨麻疹皮疹病史的儿童再次接种没有已知的或理论上增加的风险。

相似文献

1
Smallpox vaccination reactions, prophylaxis, and therapy of complications.天花疫苗接种反应、预防及并发症治疗
Pediatrics. 1975 Mar;55(3):342-7.
2
Smallpox vaccination and adverse reactions. Guidance for clinicians.天花疫苗接种与不良反应。临床医生指南。
MMWR Recomm Rep. 2003 Feb 21;52(RR-4):1-28.
3
Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).在事件前疫苗接种计划中使用天花疫苗的建议。免疫实践咨询委员会(ACIP)和医疗保健感染控制实践咨询委员会(HICPAC)的补充建议。
MMWR Recomm Rep. 2003 Apr 4;52(RR-7):1-16.
4
Clinical efficacy of intramuscular vaccinia immune globulin: a literature review.肌肉注射牛痘免疫球蛋白的临床疗效:文献综述
Clin Infect Dis. 2004 Sep 15;39(6):819-26. doi: 10.1086/422999. Epub 2004 Aug 23.
5
Pregnancy discovered after smallpox vaccination: Is vaccinia immune globulin appropriate?天花疫苗接种后发现怀孕:牛痘免疫球蛋白是否适用?
Am J Obstet Gynecol. 2004 Dec;191(6):1863-7. doi: 10.1016/j.ajog.2004.07.014.
6
Post-vaccinial complications. Report of 45 cases.疫苗接种后并发症。45例报告。
Helv Paediatr Acta. 1969 Aug;24(4):378-89.
7
[The problem of smallpox vaccination].[天花疫苗接种问题]
Harefuah. 1972 Mar 1;82(5):226-8.
8
Adverse events occurring after smallpox vaccination.天花疫苗接种后出现的不良事件。
Semin Pediatr Infect Dis. 2003 Jul;14(3):189-95. doi: 10.1016/s1045-1870(03)00032-3.
9
Risks of serious complications and death from smallpox vaccination: a systematic review of the United States experience, 1963-1968.天花疫苗接种导致严重并发症和死亡的风险:对1963 - 1968年美国经验的系统评价
BMC Public Health. 2003 Aug 11;3:26. doi: 10.1186/1471-2458-3-26.
10
Vaccinia immune globulin: current policies, preparedness, and product safety and efficacy.牛痘免疫球蛋白:现行政策、防范措施以及产品安全性和有效性
Int J Infect Dis. 2006 May;10(3):193-201. doi: 10.1016/j.ijid.2005.12.001. Epub 2006 Mar 27.

引用本文的文献

1
Unraveling Monkeypox: An Emerging Threat in Global Health.解读猴痘:全球健康领域的新威胁
Cureus. 2023 Aug 23;15(8):e43961. doi: 10.7759/cureus.43961. eCollection 2023 Aug.
2
Computational studies on searching potential phytochemicals against DNA polymerase activity of the monkeypox virus.针对猴痘病毒DNA聚合酶活性搜索潜在植物化学物质的计算研究。
J Tradit Complement Med. 2023 May 8;13(5):465-78. doi: 10.1016/j.jtcme.2023.04.002.
3
Monkeypox virus neurological manifestations in comparison to other orthopoxviruses.猴痘病毒与其他正痘病毒的神经系统表现比较。
Travel Med Infect Dis. 2022 Sep-Oct;49:102414. doi: 10.1016/j.tmaid.2022.102414. Epub 2022 Aug 2.
4
Recommendations for dermatologists treating patients with atopic dermatitis during the Covid-19 pandemic: a look into the past for a conscious vaccination management.特应性皮炎患者皮肤科治疗专家建议:从过去展望新冠疫情下的疫苗接种管理。
Hum Vaccin Immunother. 2021 Oct 3;17(10):3268-3275. doi: 10.1080/21645515.2021.1925502. Epub 2021 Jun 25.
5
The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platform.布莱顿合作组织的改良安卡拉病毒(MVA)疫苗平台风险/效益评估关键信息采集标准化模板。
Vaccine. 2021 May 21;39(22):3067-3080. doi: 10.1016/j.vaccine.2020.08.050. Epub 2020 Oct 17.
6
Production of a Chikungunya Vaccine Using a CHO Cell and Attenuated Viral-Based Platform Technology.使用 CHO 细胞和减毒病毒为基础的平台技术生产基孔肯雅热疫苗。
Mol Ther. 2017 Oct 4;25(10):2332-2344. doi: 10.1016/j.ymthe.2017.06.017. Epub 2017 Jul 15.
7
A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis.一项多中心、开放标签、对照的II期研究,旨在评估MVA天花疫苗(IMVAMUNE)在18至40岁诊断为特应性皮炎的受试者中的安全性和免疫原性。
PLoS One. 2015 Oct 6;10(10):e0138348. doi: 10.1371/journal.pone.0138348. eCollection 2015.
8
Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial.改良安卡拉牛痘疫苗-巴伐利亚北欧天花疫苗在未曾接种过天花疫苗和有经验的人类免疫缺陷病毒感染者中的安全性和免疫原性:一项开放标签、对照的临床 II 期试验。
Open Forum Infect Dis. 2015 May 5;2(2):ofv040. doi: 10.1093/ofid/ofv040. eCollection 2015 Apr.
9
[Johann Gottfried Bremser (1767-1827) as a protagonist of the cowpox vaccine].[约翰·戈特弗里德·布雷姆泽(1767 - 1827)作为牛痘疫苗的倡导者]
Wien Klin Wochenschr. 2014 Apr;126 Suppl 1:S3-10. doi: 10.1007/s00508-013-0445-9. Epub 2013 Nov 19.
10
Epitope mapping by random peptide phage display reveals essential residues for vaccinia extracellular enveloped virion spread.通过随机肽噬菌体展示进行表位作图揭示了痘苗病毒细胞外包膜病毒传播所必需的关键残基。
Virol J. 2012 Sep 24;9:217. doi: 10.1186/1743-422X-9-217.